Genetic Findings in Anorexia and Bulimia Nervosa

Progress in Molecular Biology and Translational Science

Volumn 94, Issue , 2010, Pages 241-270

  Hinney, Anke ^a   Scherag, Susann ^a   Hebebrand, Johannes ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

5 HT2A receptor gene; Genome wide association studies; Melanocortin 4 receptor gene

Indexed keywords

ANOREXIA; BULIMIA; ENVIRONMENT; GENETIC ASSOCIATION; GENETICS; HUMAN; REVIEW; TWINS;

ANOREXIA; BULIMIA NERVOSA; ENVIRONMENT; GENOME-WIDE ASSOCIATION STUDY; HUMANS; TWIN STUDIES AS TOPIC;

MLCS; MLOWN;

EID: 79960931737     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/B978-0-12-375003-7.00009-1     Document Type: Chapter

References (186)

1. American Psychiatric Association (APA), Diagnostic and statistical manual of mental disorders, 4th ed., 1994, American Psychiatric Association, Washington Text Revision.
2. World Health Organization. ICD-10. International classification of mental and behavioural disorders. Clinical description and diagnostic guidelines, 1992, WHO, Geneva.
3. Becker, A.E., Eddy, K.T., Perloe, A., Clarifying criteria for cognitive signs and symptoms for eating disorders in DSM-V. Int J Eat Disord 42 (2009), 611–619.
4. Hebebrand, J., Casper, R., Treasure, J., Schweiger, U., The need to revise the diagnostic criteria for anorexia nervosa. J Neural Transm 111 (2004), 827–840.
5. van Hoeken, D., Veling, W., Sinke, S., Mitchell, J.E., Hoek, H.W., The validity and utility of subtyping bulimia nervosa. Int J Eat Disord 42 (2009), 595–602.
6. Wilson, G.T., Sysko, R., Frequency of binge eating episodes in bulimia nervosa and binge eating disorder: diagnostic considerations. Int J Eat Disord 42 (2009), 603–610.
7. Anderluh, M., Tchanturia, K., Rabe-Hesketh, S., Collier, D., Treasure, J., Lifetime course of eating disorders: design and validity testing of a new strategy to define the eating disorders phenotype. Psychol Med 1 (2009), 1–10.
8. Bulik, C., Sullivan, P.F., Fear, J., Pickering, A., Predictors of the development of bulimia nervosa in women with anorexia nervosa. J Nerv Ment Dis 185 (1997), 704–707.
9. Eckert, E.D., Halmi, K.A., Marchi, P., Grove, W., Crosby, R., Ten-year follow-up of anorexia nervosa: clinical course and outcome. Psychol Med 25 (1995), 143–156.
10. Eddy, K.T., Dorer, D.J., Franko, D.L., Tahilani, K., Thompson-Brenner, H., Herzog, D.B., Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM-V. Am J Psychiatry 165 (2008), 245–250.
11. Fichter, M.M., Quadflieg, N., Hedlund, S., Twelve-year course and outcome predictors of anorexia nervosa. Int J Eat Disord 39 (2006), 87–100.
12. Fichter, M.M., Quadflieg, N., Long-term stability of eating disorder diagnoses. Int J Eat Disord 40 (2007), S61–S66.
13. Gillberg, I.C., Rastam, M., Gillberg, C., Anorexia nervosa outcome: six-year controlled longitudinal study of 51 cases including a population cohort. J Am Acad Child Adol Psychiatry 33 (1994), 729–739.
14. Keel, P., Dorer, D., Franko, D., Jackson, S., Herzog, D., Postremission predictors of relapse in women with eating disorders. Am J Psychiatry 162 (2005), 2263–2268.
15. Milos, G., Spindler, A., Schnyder, U., Fairburn, C.G., Instability of eating disorder diagnoses: prospective study. Br J Psychiatry 187 (2005), 573–578.
16. Nishimura, H., Komaki, G., Ando, T., Nakahara, T., Oka, T., Kawai, K., et al. Psychological and weight-related characteristics of patients with anorexia nervosa-restricting type who later develop bulimia nervosa. Biopsychosoc Med, 2, 2008, 5.
17. Strober, M., Freeman, R., Morrell, W., The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10–15 years in a prospective study. Int J Eat Disord 22 (1997), 339–360.
18. Tozzi, F., Thornton, L., Klump, K., Bulik, C., Fichter, M., Halmi, K., et al. Symptom fluctuation in eating disorders: correlates of diagnostic crossover. Am J Psychiatry 162 (2005), 732–740.
19. van der Ham, T., van Strien, D., van Engeland, H., A four-year prospective follow-up study of 49 eating-disordered adolescents: differences in course of illness. Acta Psychiatr Scand 90 (1994), 229–235.
20. Bulik, C.M., Sullivan, P.F., Wade, T.D., Kendler, K.S., Twin studies of eating disorders: a review. Int J Eat Disord 27 (2000), 1–20.
21. Holland, A.J., Hall, A., Murray, R., Russell, G.F., Crisp, A.H., Anorexia nervosa: a study of 34 twin pairs and one set of triplets. Br J Psychiatry 145 (1984), 414–419.
22. Holland, A.J., Sicotte, N., Treasure, J., Anorexia nervosa: evidence for a genetic basis. J Psychosom Res 32 (1988), 561–571.
23. Kipman, A., Gorwood, P., Mouren-Siméoni, M.C., Adès, J., Genetic factors in anorexia nervosa. Eur Psychiatry 14 (1999), 189–198.
24. Klump, K.L., Kaye, W.H., Strober, M., The evolving genetic foundations of eating disorders. Psychiatr Clin North Am 24 (2001), 215–225.
25. Klump, K.L., Miller, K.B., Keel, P.K., McGue, M., Iacono, W.G., Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol Med 31 (2001), 737–740.
26. Klump, K.L., Wonderlich, S., Lehoux, P., Lilenfeld, L.R., Bulik, C.M., Does environment matter? A review of nonshared environment and eating disorders. Int J Eat Disord 31 (2002), 118–135.
27. Bulik, C.M., Slof-Op't Landt, M.C., van Furth, E.F., Sullivan, P.F., The genetics of anorexia nervosa. Annu Rev Nutr 27 (2007), 263–275.
28. Fairburn, C.G., Harrison, P.J., Eating disorders. Lancet 361 (2003), 407–416.
29. Gorwood, P., Eating disorders, serotonin transporter polymorphisms and potential treatment response. Am J Pharmacogenomics 4 (2004), 9–17.
30. Klump, K.L., Holly, A., Iaconom, W.G., McGue, M., Willson, L.E., Physical similarity and twin resemblance for eating attitudes and behaviors: a test of the equal environments assumption. Behav Genet 30 (2000), 51–58.
31. Bulik, C.M., Sullivan, P.F., Kendler, K.S., Heritability of binge-eating and broadly defined bulimia nervosa. Biol Psychiatry 44 (1998), 1210–1218.
32. Kendler, K.S., MacLean, C., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., The genetic epidemiology of bulimia nervosa. Am J Psychiatry 148 (1991), 1627–1637.
33. Kendler, K.S., Walters, E.E., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52 (1995), 374–383.
34. Wade, T.D., Bulik, C.M., Neale, M., Kendler, K.S., Anorexia nervosa and major depression: shared genetic and environmental risk factors. Am J Psychiatry 157 (2000), 469–471.
35. Kortegaard, L.S., Hoerder, K., Joergensen, J., Gillberg, C., Kyvik, K.O., A preliminary population-based twin study of self-reported eating disorder. Psychol Med 31 (2001), 361–365.
36. Walters, E.E., Kendler, K.S., Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am J Psychiatry 152 (1995), 64–71.
37. Bulik, C.M., Thornton, L.M., Root, T.L., Pisetsky, E.M., Lichtenstein, P., Pedersen, N.L., Understanding the relation between anorexia nervosa and bulimia nervosa in a Swedish national twin sample. Biol Psychiatry 67 (2010), 71–77.
38. Strober, M., Freeman, R., Lampert, C., Diamond, J., Kaye, W., Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry 157 (2000), 393–401.
39. Hinney, A., Remschmidt, H., Hebebrand, J., Candidate gene polymorphisms in eating disorders. Eur J Pharmacol 410 (2000), 147–159.
40. Coners, H., Remschmidt, H., Hebebrand, J., The relationship between premorbid body weight, weight loss, and weight at referral in adolescent patients with anorexia nervosa. Int J Eat Disord 26 (1999), 171–178.
41. Fairburn, C.G., Cooper, Z., Doll, H.A., Welch, S.L., Risk factors for anorexia nervosa: three integrated case–control comparisons. Arch Gen Psychiatry 56 (1999), 468–476.
42. Spielman, R.S., McGinnis, R.E., Ewens, W.J., Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52 (1993), 506–516.
43. Risch, N., Merikangas, K., The future of genetic studies of complex human diseases. Science 273 (1996), 1516–1517.
44. Hebebrand, J., Scherag, A., Schimmelmann, B.G., Hinney, A., Child and adolescent psychiatric genetics. Eur Child Adolesc Psychiatry 19 (2010), 259–279.
45. Lander, E., Kruglyak, L., Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 (1995), 241–247.
46. Kaye, W.H., Frank, G.K., McConaha, C., Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharmacology 21 (1999), 503–506.
47. Kaye, W.H., Klump, K.L., Frank, G.K., Strober, M., Anorexia and bulimia nervosa. Annu Rev Med 51 (2000), 299–313.
48. Kaye, W.H., Bulik, C.M., Thornton, L., Barbarich, N., Masters, K., Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 161 (2004), 2215–2221.
49. Kaye, W.H., Fudge, J.L., Paulus, M., New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 10 (2009), 573–584.
50. Kaye, W.H., Greeno, C.G., Moss, H., Fernstrom, J., Fernstrom, M., Lilenfeld, L.R., et al. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 55 (1998), 927–935.
51. Kaye, W.H., Gwirtsman, H.E., George, D.T., Ebert, M.H., Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?. Arch Gen Psychiatry 48 (1991), 556–562.
52. Barry, V.C., Klawans, H.L., On the role of dopamine in the pathophysiology of anorexia nervosa. J Neural Transm 38 (1976), 107–122.
53. Golden, N.H., Shenker, I.R., Amenorrhea in anorexia nervosa. Neuroendocrine control of hypothalamic dysfunction. Int J Eat Disord 16 (1994), 53–60.
54. Wagner, A., Aizenstein, H., Venkatraman, V.K., Fudge, J., May, J.C., Mazurkewicz, L., et al. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 164 (2007), 1842–1849.
55. Wagner, A., Aizenstein, H., Venkatraman, V.K., Bischoff-Grethe, A., Fudge, J., May, J.C., et al. Altered striatal response to reward in bulimia nervosa after recovery. Int J Eat Disord 43 (2010), 289–294.
56. Keating, C., Theoretical perspective on anorexia nervosa: the conflict of reward. Neurosci Biobehav Rev 34 (2010), 73–79.
57. Vaz-Leal, F.J., Santos, L.R., García-Herráiz, M.A., Monge-Bautista, M., López-Vinuesa, B., Bulimia nervosa with history of anorexia nervosa: could the clinical subtype of anorexia have implications for clinical status and treatment response?. Int J Eat Disord, 2010 [Epub ahead of print].
58. Hebebrand, J., Remschmidt, H., Anorexia nervosa viewed as an extreme weight condition: genetic implications. Hum Genet 95 (1995), 1–11.
59. Blundell, J.E., Lawton, C.L., Halford, J.C., Serotonin, eating behavior, and fat intake. Obes Res 3 (1995), 471S–476.
60. Halford, J.C., Blundell, J.E., Separate systems for serotonin and leptin in appetite control. Ann Med 32 (2000), 222–232.
61. Wurtman, R.J., Wurtman, J.J., Brain serotonin, carbohydrate-craving, obesity and depression. Adv Exp Med Biol 398 (1996), 35–41.
62. Brewerton, T.D., Jimerson, D.C., Studies of serotonin function in anorexia nervosa. Psychiatry Res 62 (1996), 31–42.
63. Jimerson, D.C., Lesem, M.D., Kaye, W.H., Brewerton, T.D., Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49 (1992), 132–138.
64. Scherag, S., Hebebrand, J., Hinney, A., Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry 19 (2010), 211–226.
65. Collier, D.A., Arranz, M.J., Li, T., Mupita, D., Brown, N., Treasure, J., Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet, 350, 1997, 412.
66. Enoch, M.A., Kaye, W.H., Rotondo, A., Greenberg, B.D., Murphy, D.L., Goldman, D., 5-HT2A promoter polymorphism—1438G/A, anorexia nervosa, and obsessive–compulsive disorder. Lancet 351 (1998), 1785–1786.
67. Nacmias, B., Ricca, V., Tedde, A., Mezzani, B., Rotella, C.M., Sorbi, S., 5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa. Neurosci Lett 277 (1999), 134–136.
68. Rybakowski, F., Slopien, A., Dmitrzak-Weglarz, M., Czerski, P., Rajewski, A., Hauser, J., The 5-HT2A − 1438 A/G and 5-HTTLPR polymorphisms and personality dimensions in adolescent anorexia nervosa: association study. Neuropsychobiology 53 (2006), 33–39.
69. Sorbi, S., Nacmias, B., Tedde, A., Ricca, V., Mezzani, B., Rotella, C.M., 5-HT2A promoter polymorphism in anorexia nervosa. Lancet, 351, 1998, 1785.
70. Ando, T., Komaki, G., Karibe, M., Kawamura, N., Hara, S., Takii, M., et al. 5-HT2A promoter polymorphism is not associated with anorexia nervosa in Japanese patients. Psychiatr Genet 11 (2001), 157–160.
71. Campbell, D.A., Sundaramurthy, D., Markham, A.F., Pieri, L.F., Lack of association between 5-HT2A gene promoter polymorphism and susceptibility to anorexia nervosa. Lancet, 351, 1998, 499.
72. Gorwood, P., Adès, J., Bellodi, L., Cellini, E., Collier, D.A., Di Bella, D., et al. The 5-HT(2A) − 1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres. Mol Psychiatry 7 (2002), 90–94.
73. Nishiguchi, N., Matsushita, S., Suzuki, K., Murayama, M., Shirakawa, O., Higuchi, S., Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biol Psychiatry 50 (2001), 123–128.
74. Hinney, A., Ziegler, A., Nöthen, M.M., Remschmidt, H., Hebebrand, J., 5-HT2A receptor gene polymorphisms, anorexia nervosa, and obesity. Lancet 350 (1997), 1324–1325.
75. Ziegler, A., Hebebrand, J., Görg, T., Rosenkranz, K., Fichter, M., Herpertz-Dahlmann, B., et al. Further lack of association between the 5-HT2A gene promoter polymorphism and susceptibility to eating disorders and a meta-analysis pertaining to anorexia nervosa. Mol Psychiatry 4 (1999), 410–412.
76. Gorwood, P., Kipman, A., Foulon, C., The human genetics of anorexia nervosa. Eur J Pharmacol 480 (2003), 163–170.
77. Hinney, A., Barth, N., Ziegler, A., von Prittwitz, S., Hamann, A., Hennighausen, K., et al. Serotonin transporter gene-linked polymorphic region: allele distributions in relationship to body weight and in anorexia nervosa. Life Sci 61 (1997), 295–303.
78. Matsushita, S., Suzuki, K., Murayama, M., Nishiguchi, N., Hishimoto, A., Takeda, A., et al. Serotonin transporter regulatory region polymorphism is associated with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 128 (2004), 114–117.
79. Sundaramurthy, D., Pieri, L.F., Gape, H., Markham, A.F., Campbell, D.A., Analysis of the serotonin transporter gene linked polymorphism (5-HTTLPR) in anorexia nervosa. Am J Med Genet 96 (2000), 53–55.
80. Lauzurica, N., Hurtado, A., Escartí, A., Delgado, M., Barrios, V., Morandé, G., et al. Polymorphisms within the promoter and the intron 2 of the serotonin transporter gene in a population of bulimic patients. Neurosci Lett 352 (2003), 226–230.
81. Calati, R., De Ronchi, D., Bellini, M., Serretti, A., The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. Int J Eat Disord, 2010 [Epub ahead of print].
82. Bergen, A.W., Yeager, M., Welch, R.A., Haque, K., Ganjei, J.K., van den Bree, M.B., et al. Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology 30 (2005), 1703–1710.
83. Nisoli, E., Brunani, A., Borgomainerio, E., Tonello, C., Dioni, L., Briscini, L., et al. D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 12 (2007), 91–96.
84. Bachner-Melman, R., Lerer, E., Zohar, A.H., Kremer, I., Elizur, Y., Nemanov, L., et al. Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4). Am J Med Genet B Neuropsychiatr Genet 144 (2007), 748–756.
85. Hinney, A., Schneider, J., Ziegler, A., Lehmkuhl, G., Poustka, F., Schmidt, M.H., et al. No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight, and obesity. Am J Med Genet 88 (1999), 594–597.
86. Karwautz, A., Rabe-Hesketh, S., Hu, X., Zhao, J., Sham, P., Collier, D.A., et al. Individual-specific risk factors for anorexia nervosa: a pilot study using a discordant sister-pair design. Psychol Med 31 (2001), 317–329.
87. Levitan, R.D., Masellis, M., Basile, V.S., Lam, R.W., Kaplan, A.S., Davis, C., et al. The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry 56 (2004), 665–669.
88. Kaplan, A.S., Levitan, R.D., Yilmaz, Z., Davis, C., Tharmalingam, S., Kennedy, J.L., A DRD4/BDNF gene–gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord 41 (2008), 22–28.
89. Di Marzo, V., Bifulco, M., De Petrocellis, L., The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3 (2004), 771–784.
90. Siegfried, Z., Kanyas, K., Latzer, Y., Karni, O., Bloch, M., Lerer, B., et al. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes. Am J Med Genet B Neuropsychiatr Genet 125 (2004), 126–130.
91. Müller, T.D., Reichwald, K., Brönner, G., Kirschner, J., Nguyen, T.T., Scherag, A., et al. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adolesc Psychiatry Ment Health, 2, 2008, 33.
92. Monteleone, P., Bifulco, M., Di Filippo, C., Gazzerro, P., Canestrelli, B., Monteleone, F., et al. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. Genes Brain Behav 8 (2009), 728–732.
93. Hinney, A., Vogel, C.I., Hebebrand, J., From monogenic to polygenic obesity: recent advances. Eur Child Adolesc Psychiatry 19 (2010), 297–310.
94. Ahima, R.S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., et al. Role of leptin in the neuroendocrine response to fasting. Nature 382 (1996), 250–252.
95. Hebebrand, J., Blum, W.F., Barth, N., Coners, H., Englaro, P., Juul, A., et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 2 (1997), 330–334.
96. Hebebrand, J., Müller, T.D., Holtkamp, K., Herpertz-Dahlmann, B., The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry 12 (2007), 23–35.
97. Grinspoon, S., Gulick, T., Askari, H., Landt, M., Lee, K., Anderson, E., et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 81 (1996), 3861–3863.
98. Haas, V., Onur, S., Paul, T., Nutzinger, D.O., Bosy-Westphal, A., Hauer, M., et al. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am J Clin Nutr 81 (2005), 889–896.
99. Hebebrand, J., van der Heyden, J., Devos, R., Köpp, W., Herpertz, S., Remschmidt, H., et al. Plasma concentrations of obese protein in anorexia nervosa. Lancet 346 (1995), 1624–1625.
100. Holtkamp, K., Mika, C., Grzella, I., Heer, M., Pak, H., Hebebrand, J., et al. Reproductive function during weight gain in anorexia nervosa. Leptin represents a metabolic gate to gonadotropin secretion. J Neural Transm 110 (2003), 427–435.
101. Frey, J., Hebebrand, J., Müller, B., Ziegler, A., Blum, W.F., Remschmidt, H., et al. Reduced body fat in long-term followed-up female patients with anorexia nervosa. J Psychiatr Res 34 (2000), 83–88.
102. Haluzík, M., Papezová, M., Nedvídková, J., Kábrt, J., Serum leptin levels in patients with anorexia nervosa before and after partial refeeding, relationships to serum lipids and biochemical nutritional parameters. Physiol Res 48 (1999), 197–202.
103. Gendall, K.A., Kaye, W.H., Altemus, M., McConaha, C.W., La Via, M.C., Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry 46 (1999), 292–299.
104. Hinney, A., Bornscheuer, A., Depenbusch, M., Mierke, B., Tölle, A., Middeke, K., et al. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Mol Psychiatry 3 (1998), 539–543.
105. Quinton, N.D., Meechan, D.W., Brown, K., Eastwood, H., Blakemore, A.I., Single nucleotide polymorphisms in the leptin receptor gene: studies in anorexia nervosa. Psychiatr Genet 14 (2004), 191–194.
106. Vink, T., Hinney, A., van Elburg, A.A., van Goozen, S.H., Sandkuijl, L.A., Sinke, R.J., et al. Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol Psychiatry 6 (2001), 325–358.
107. Dardennes, R.M., Zizzari, P., Tolle, V., Foulon, C., Kipman, A., Romo, L., et al. Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology 32 (2007), 106–113.
108. Farooqi, I.S., Yeo, G.S., Keogh, J.M., Aminian, S., Jebb, S.A., Butler, G., et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106 (2000), 271–279.
109. Hinney, A., Bettecken, T., Tarnow, P., Brumm, H., Reichwald, K., Lichtner, P., et al. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J Clin Endocrinol Metab 91 (2006), 1761–1769.
110. Hinney, A., Hohmann, S., Geller, F., Vogel, C., Hess, C., Wermter, A.K., et al. Melanocortin-4 receptor gene: case–control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 88 (2003), 4258–4267.
111. Hinney, A., Schmidt, A., Nottebom, K., Heibült, O., Becker, I., Ziegler, A., et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 84 (1999), 1483–1486.
112. Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., Froguel, P., Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106 (2000), 253–262.
113. Vaisse, C., Clement, K., Guy-Grand, B., Froguel, P., A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20 (1998), 113–114.
114. Yeo, G.S., Farooqi, I.S., Aminian, S., Halsall, D.J., Stanhope, R.G., O'Rahilly, S., A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20 (1998), 111–112.
115. Hebebrand, J., Fichter, M., Gerber, G., Görg, T., Hermann, H., Geller, F., et al. Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene. Mol Psychiatry 7 (2002), 647–651.
116. Branson, R., Potoczna, N., Kral, J.G., Lentes, K.U., Hoehe, M.R., Horber, F.F., Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 348 (2003), 1096–1103.
117. Potoczna, N., Branson, R., Kral, J.G., Piec, G., Steffen, R., Ricklin, T., Hoehe, M.R., Lentes, K.U., Horber, F.F., Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg 8 (2004), 971–981 [discussion 981–982].
118. Geller, F., Reichwald, K., Dempfle, A., Illig, T., Vollmert, C., Herpertz, S., et al. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 74 (2004), 572–581.
119. Wang, D., Ma, J., Zhang, S., Hinney, A., Hebebrand, J., Wang, Y., et al. Association of the MC4R V103I polymorphism with obesity: a Chinese case–control study and meta-analysis in 55, 195 individuals. Obesity (Silver Spring) 18 (2010), 573–579.
120. Herpertz, S., Siffert, W., Hebebrand, J., Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 349 (2003), 606–609 [author reply 606–609].
121. Hebebrand, J., Geller, F., Dempfle, A., Heinzel-Gutenbrunner, M., Raab, M., Gerber, G., et al. Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations. Mol Psychiatry 9 (2004), 796–800.
122. Xu, B., Goulding, E.H., Zang, K., Cepoi, D., Cone, R.D., Jones, K.R., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6 (2003), 736–742.
123. Nakazato, M., Hashimoto, K., Shimizu, E., Kumakiri, C., Koizumi, H., Okamura, N., et al. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54 (2003), 485–490.
124. Nakazato, M., Hashimoto, K., Yoshimura, K., Hashimoto, T., Shimizu, E., Iyo, M., No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006), 1117–1121.
125. Monteleone, P., Fabrazzo, M., Martiadis, V., Serritella, C., Pannuto, M., Maj, M., Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables. Psychol Med 35 (2005), 897–905.
126. Monteleone, P., Tortorella, A., Martiadis, V., Serritella, C., Fuschino, A., Maj, M., Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 66 (2004), 744–748.
127. Ehrlich, S., Salbach-Andrae, H., Eckart, S., Merle, J.V., Burghardt, R., Pfeiffer, E., et al. Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa. J Psychiatry Neurosci 34 (2009), 323–329.
128. Ribasés, M., Gratacòs, M., Armengol, L., de Cid, R., Badía, A., Jiménez, L., et al. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 8 (2003), 745–751.
129. Ribasés, M., Gratacòs, M., Fernández-Aranda, F., Bellodi, L., Boni, C., Anderluh, M., et al. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet 13 (2004), 1205–1212.
130. Ribasés, M., Gratacòs, M., Fernández-Aranda, F., Bellodi, L., Boni, C., Anderluh, M., et al. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet 13 (2005), 428–434.
131. Dmitrzak-Weglarz, M., Skibinska, M., Slopien, A., Szczepankiewicz, A., Rybakowski, F., Kramer, L., et al. BDNF Met66 allele is associated with anorexia nervosa in the Polish population. Psychiatr Genet 17 (2007), 245–246.
132. Friedel, S., Horro, F.F., Wermter, A.K., Geller, F., Dempfle, A., Reichwald, K., et al. Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 132 (2005), 96–99.
133. Rybakowski, F., Dmitrzak-Weglarz, M., Szczepankiewicz, A., Skibinska, M., Slopien, A., Rajewski, A., et al. Brain derived neurotrophic factor gene Val66Met and − 270C/T polymorphisms and personality traits predisposing to anorexia nervosa. Neuro Endocrinol Lett 28 (2007), 153–158.
134. Mercader, J.M., Saus, E., Agüera, Z., Bayés, M., Boni, C., Carreras, A., et al. Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders. Hum Mol Genet 17 (2008), 1234–1244.
135. Ribases, M., Gratacos, M., Badia, A., Jimenez, L., Solano, R., Vallejo, J., et al. Contribution of NTRK2 to the genetic susceptibility to anorexia nervosa, harm avoidance and minimum body mass index. Mol Psychiatry 10 (2005), 851–860.
136. Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M., Lindgren, C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 (2007), 889–894.
137. Hinney, A., Nguyen, T.T., Scherag, A., Friedel, S., Brönner, G., Müller, T.D., et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One, 2, 2007, 1361.
138. Willer, C.J., Speliotes, E.K., Loos, R.J., Li, S., Lindgren, C.M., Heid, I.M., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41 (2009), 25–34.
139. Brandys, M.K., van Elburg, A.A., Loos, R.J., Bauer, F., Hendriks, J., van der Schouw, Y.T., et al. Are recently identified genetic variants regulating BMI in the general population associated with anorexia nervosa?. Am J Med Genet B Neuropsychiatr Genet 153 (2010), 695–699.
140. Kaye, W.H., Lilenfeld, L.R., Berrettini, W.H., Strober, M., Devlin, B., Klump, K.L., et al. A search for susceptibility loci for anorexia nervosa: methods and sample description. Biol Psychiatry 47 (2000), 794–803.
141. Grice, D.E., Halmi, K.A., Fichter, M.M., Strober, M., Woodside, D.B., Treasure, J.T., et al. Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet 70 (2002), 787–792.
142. Bergen, A.W., van den Bree, M.B., Yeager, M., Welch, R., Ganjei, J.K., Haque, K., et al. Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mol Psychiatry 8 (2003), 397–406.
143. Brown, K.M., Bujac, S.R., Mann, E.T., Campbell, D.A., Stubbins, M.J., Blundell, J.E., Further evidence of association of OPRD1 & HTR1D polymorphisms with susceptibility to anorexia nervosa. Biol Psychiatry 61 (2007), 367–373.
144. Devlin, B., Bacanu, S.A., Klump, K.L., Bulik, C.M., Fichter, M.M., Halmi, K.A., et al. Linkage analysis of anorexia nervosa incorporating behavioral covariates. Hum Mol Genet 11 (2002), 689–696.
145. Bulik, C.M., Devlin, B., Bacanu, S.A., Thornton, L., Klump, K.L., Fichter, M.M., et al. Significant linkage on chromosome 10p in families with bulimia nervosa. Am J Hum Genet 72 (2003), 200–207.
146. Dong, C., Wang, S., Li, W.D., Li, D., Zhao, H., Price, R.A., Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am J Hum Genet 72 (2003), 115–124.
147. Hager, J., Dina, C., Francke, S., Dubois, S., Houari, M., Vatin, V., et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 20 (1998), 304–308.
148. Hinney, A., Ziegler, A., Oeffner, F., Wedewardt, C., Vogel, M., Wulftange, H., et al. Independent confirmation of a major locus for obesity on chromosome 10. J Clin Endocrinol Metab 85 (2000), 2962–2965.
149. Price, R.A., Li, W.D., Bernstein, A., Crystal, A., Golding, E.M., Weisberg, S.J., et al. A locus affecting obesity in human chromosome region 10p12. Diabetologia 44 (2001), 363–366.
150. Boutin, P., Dina, C., Vasseur, F., Dubois, S., Corset, L., Séron, K., et al. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol, 1, 2003, 68.
151. Swarbrick, M.M., Waldenmaier, B., Pennacchio, L.A., Lind, D.L., Cavazos, M.M., Geller, F., et al. Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biol, 3, 2005, 315.
152. Thorleifsson, G., Walters, G.B., Gudbjartsson, D.F., Steinthorsdottir, V., Sulem, P., Helgadottir, A., et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41 (2009), 18–24.
153. Freimer, N.B., Sabatti, C., Human genetics: variants in common diseases. Nature 445 (2007), 828–830.
154. Wermter, A.K., Laucht, M., Schimmelmann, B.G., Banaschweski, T., Sonuga-Barke, E.J., Rietschel, M., et al. From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders. Eur Child Adolesc Psychiatry 19 (2010), 199–210.
155. Mazzeo, S.E., Bulik, C.M., Environmental and genetic risk factors for eating disorders: what the clinician needs to know. Child Adolesc Psychiatr Clin N Am 18 (2009), 67–82.
156. Dempfle, A., Scherag, A., Hein, R., Beckmann, L., Chang-Claude, J., Schäfer, H., Gene–environment interactions for complex traits: definitions, methodological requirements and challenges. Eur J Hum Genet 16 (2008), 1164–1172.
157. Maher, B., Personal genomes: the case of the missing heritability. Nature 456 (2008), 18–21.
158. Psychiatric GWAS Consortium Coordinating Committee Cichon, S., Craddock, N., Daly, M., Faraone, S.V., Gejman, P.V., et al. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166 (2009), 540–556.
159. Hinney, A., Herrmann, H., Lohr, T., Rosenkranz, K., Ziegler, A., Lehmkuhl, G., et al. No evidence for an involvement of alleles of polymorphisms in the serotonin (1D beta and 7) receptor genes in obesity, underweight or anorexia nervosa. Int J Obes 23 (1999), 760–763.
160. Urwin, R.E., Bennetts, B.H., Wilcken, B., Beumont, P.J.V., Russell, J.D., Nunn, K.P., Investigation of epistasis between the serotonin transporter and norepinephrine transporter genes in anorexia nervosa. Neuropsychopharmacology 28 (2003), 1351–1355.
161. Dmitrzak-Weglarz, M., Skibinska, M., Slopien, A., Szczepankiewicz, A., Rybakowski, F., Kramer, L., et al. BDNF Met66 allele is associated with anorexia nervosa in the Polish population. Psychiatr Genet 17 (2007), 245–246.
162. Hu, X., Murphy, F., Karwautz, A., Li, T., Freeman, B., Franklin, D., et al. Analysis of microsatellite markers at the UCP2/UCP3 locus on chromosome 11q13 in anorexia nervosa. Mol Psychiatry 7 (2002), 276–277.
163. Koronyo-Hamaoui, M., Danziger, Y., Frisch, A., Stein, D., Leor, S., Laufer, N., et al. Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study. Mol Psychiatry 7 (2002), 82–85.
164. Rosenkranz, K., Hinney, A., Ziegler, A., Hermann, H., Fichter, M., Mayer, H., et al. Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab 83 (1998), 4524–4527.
165. Mikolajczyk, E., Grzywacz, A., Samochowiec, J., The association of catechol-O-methyltransferase genotype with the phenotype of women with eating disorders. Brain Res 1307 (2010), 142–148.
166. Michaelovsky, E., Frisch, A., Leor, S., Stein, D., Danziger, Y., Carel, C., et al. Haplotype analysis of the COMT–ARVCF gene region in Israeli anorexia nervosa family trios. Am J Med Genet B Neuropsychiatr Genet 139 (2005), 45–50.
167. Di Bella, D., Catalano, M., Cavallini, M.C., Riboldi, C., Bellodi, L., Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa. Mol Psychiatry 5 (2000), 233–234.
168. Frieling, H., Gozner, A., Römer, K.D., Lenz, B., Bönsch, D., Wilhelm, J., et al. Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa. Mol Psychiatry 12 (2007), 229–230.
169. Rosenkranz, K., Hinney, A., Ziegler, A., von Prittwitz, S., Barth, N., Roth, H., et al. Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes. Int J Obes Relat Metab Disord 22 (1998), 157–163.
170. Gabrovsek, M., Brecelj-Anderluh, M., Bellodi, L., Cellini, E., Di Bella, D., Estivill, X., et al. Combined family trio and case–control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 124 (2004), 68–72.
171. Steiger, H., Richardson, J., Schmitz, N., Joober, R., Israel, M., Bruce, K.R., et al. Association of trait-defined, eating-disorder sub-phenotypes with (biallelic and triallelic) 5HTTLPR variations. J Psychiatr Res 43 (2009), 1086–1094.
172. Ricca, V., Nacmias, B., Cellini, E., Di Bernardo, M., Rotella, C.M., Sorbi, S., 5-HT2A receptor gene polymorphism and eating disorders. Neurosci Lett 323 (2002), 105–108.
173. Martaskova, D., Slachtova, L., Kemlink, D., Zahorakova, D., Papezova, H., Polymorphisms in serotonin-related genes in anorexia nervosa. The first study in Czech population and meta-analyses with previously performed studies. Folia Biol 55 (2009), 192–197.
174. Hammer, C., Kapeller, J., Endele, M., Fischer, C., Hebebrand, J., Hinney, A., et al. Functional variants of the serotonin receptor type 3A and B gene are associated with eating disorders. Pharmacogenet Genomics 19 (2009), 790–799.
175. Hinney, A., Becker, I., Heibült, O., Nottebom, K., Schmidt, A., Ziegler, A., et al. Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. J Clin Endocrinol Metab 83 (1998), 3737–3741.
176. Kim, Y.R., Woo, J.M., Heo, S.Y., Kim, J.H., Lim, S.J., Yu, B.H., An association study of the A218C polymorphism of the tryptophan hydroxylase 1 gene with eating disorders in a Korean population: a pilot study. Psychiatry Investig 6 (2009), 44–49.
177. Lee, Y., Lin, P.Y., Association between serotonin transporter gene polymorphism and eating disorders: a meta-analytic study. Int J Eat Disord, 2009 [Epub ahead of print].
178. Mikolajczyk, E., Smiarowska, M., Grzywacz, A., Samochowiec, J., Association of eating disorders with catechol-O-methyltransferase gene functional polymorphism. Neuropsychobiology 54 (2006), 82–86.
179. Steiger, H., Joober, R., Gauvin, L., Bruce, K.R., Richardson, J., Israel, M., et al. Serotonin-system polymorphisms (5-HTTLPR and -1438G/A) and responses of patients with bulimic syndromes to multimodal treatments. J Clin Psychiatry 69 (2008), 1565–1571.
180. Burnet, P.W., Smith, K.A., Cowen, P.J., Fairburn, C.G., Harrison, P.J., Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder. Psychiatr Genet 9 (1999), 101–104.
181. Fumeron, F., Betoulle, D., Aubert, R., Herbeth, B., Siest, G., Rigaud, D., Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol Psychiatry 6 (2001), 9–10.
182. Bruins-Slot, L., Gorwood, P., Bouvard, M., Blot, P., Ades, J., Feingold, J., et al. Lack of association between anorexia nervosa and D3 dopamine receptor gene. Biol Psychiatry 43 (1998), 76–78.
183. Han, L., Nielsen, D.A., Rosenthal, N.E., Jefferson, K., Kaye, W., Murphy, D., et al. No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive–compulsive disorder, anorexia nervosa, and alcoholism. Biol Psychiatry 45 (1999), 615–619.
184. Frisch, A., Laufer, N., Danziger, Y., Michaelovsky, E., Leor, S., Carel, C., et al. Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients. Mol Psychiatry 6 (2001), 243–245.
185. Kanbur, N., Mesci, L., Derman, O., Turul, T., Cuhadaroğlu, F., Kutluk, T., et al. Tumor necrosis factor alpha-308 gene polymorphism in patients with anorexia nervosa. Turk J Pediatr 50 (2008), 219–222.
186. Hinney, A., Lentes, K.U., Rosenkranz, K., Barth, N., Roth, H., Ziegler, A., et al. Beta 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa. Int J Obes Relat Metab Disord 21 (1997), 224–230.